$1.10
+0.0400 (+3.77%)
At Close: Jun 03, 2026
Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates
07:30pm, Wednesday, 07'th May 2025
Myomo, Inc. (MYO) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.10 per share a year ago.
Myomo Reports First Quarter 2025 Financial and Operating Results
05:11pm, Wednesday, 07'th May 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
Myomo to Host Investor & Analyst Day Event on June 18, 2025
08:30am, Thursday, 01'st May 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
Myomo to Report First Quarter 2025 Financial Results on May 7
04:05pm, Wednesday, 30'th Apr 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
Myomo Launches the MyoPro® 2x
08:05am, Wednesday, 30'th Apr 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers improved arm and hand function for individuals with upper-limb paralysis and neuro
Myomo Announces Upcoming Changes to its Board of Directors
08:30am, Thursday, 10'th Apr 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference
04:05pm, Monday, 31'st Mar 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates
06:16pm, Monday, 10'th Mar 2025
Myomo, Inc. (MYO) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.07 per share a year ago.
Myomo, Inc. (MYO) Q4 2024 Earnings Call Transcript
06:13pm, Monday, 10'th Mar 2025
Myomo, Inc. (NYSE:MYO ) Q4 2024 Earnings Conference Call March 10, 2025 4:30 PM ET Company Participants Tirth Patel - Alliance Advisors, Investor Relations Paul Gudonis - Chief Executive Officer Dave
Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million
04:05pm, Monday, 10'th Mar 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
Myomo to Report Fourth Quarter 2024 Financial Results on March 10
04:05pm, Monday, 03'rd Mar 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fro
3 Underrated Robotics Stocks Poised for Major Growth
07:46am, Monday, 03'rd Feb 2025
The days of robots being primarily limited to manufacturing applications are long gone—the industry is expanding rapidly and becoming integrated into many different sectors thanks to rapid developme
Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth
07:47am, Tuesday, 17'th Dec 2024
As 2025 approaches, several promising micro-cap stocks are gaining attention for their potential to disrupt key industries. These companies, though small in market size, are making significant strides
Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock
07:30am, Thursday, 05'th Dec 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upp
Myomo, Inc. Announces Proposed Public Offering of Common Stock
04:05pm, Wednesday, 04'th Dec 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upp
Sign In
Buy MYO